World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
26497
World Ranking
1172
National Ranking
103

Medicine

D-Index
88
Citations
26593
World Ranking
13227
National Ranking
1234

Donna E. Davies publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Donna E. Davies sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 341 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Donna E. Davies D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Donna E. Davies sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Donna E. Davies is affiliated with the University of Southampton in the United Kingdom. Their research primarily centers on medical and pulmonary sciences, with a focus on pulmonary and respiratory medicine, immunology, biomedical engineering, infectious diseases, and epidemiology. The body of work demonstrates a sustained exploration of lung-related health issues and respiratory conditions.

Their main topics of investigation include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Medical Imaging and Pathology Studies
  • Occupational and Environmental Lung Diseases
  • Air Quality and Health Impacts
  • SARS-CoV-2 and COVID-19 Research
  • Neonatal Respiratory Health Research
  • Advanced Fluorescence Microscopy Techniques

Donna E. Davies has published numerous papers, among which the following are notable recent works:

  • Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial, 2020, The Lancet Respiratory Medicine
  • A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection, 2021, Nature Genetics
  • Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis, 2022, eLife
  • Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis, 2021, Journal of Biological Chemistry
  • Spatially resolved deconvolution of the fibrotic niche in lung fibrosis, 2022, Cell Reports

The frequent co-authors collaborating with Donna E. Davies include:

  • Mark G. Jones
  • Yihua Wang
  • Elizabeth R. Davies
  • Joseph A. Bell
  • Franco Conforti

The most common venues for their publications are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal
  • The Lancet Respiratory Medicine
  • Nature Genetics
  • eLife

The researcher's work is situated mainly within medicine, comprising 50 publications, with a significant concentration in the subfield of pulmonary and respiratory medicine (27 publications). Their interests also extend to immunology, biomedical engineering, infectious diseases, and epidemiology, evidencing multidisciplinary engagement in health sciences.

Best Publications

  • Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus

    Peter A.B. Wark;Sebastian L. Johnston;Fabio Bucchieri;Robert Powell

  • Role of deficient type III interferon-λ production in asthma exacerbations

    Marco Contoli;Simon D Message;Vasile Laza-Stanca;Michael R Edwards

  • Defective epithelial barrier function in asthma.

    Chang Xiao;Sarah M. Puddicombe;Sarah Field;Joel Haywood

  • Epithelial-mesenchymal interactions in the pathogenesis of asthma.

    Stephen T. Holgate;Donna E. Davies;Peter M. Lackie;Susan J. Wilson

  • Airway remodeling in asthma: New insights

    Donna E. Davies;James Wicks;Robert M. Powell;Sarah M. Puddicombe

  • Effect of Bronchoconstriction on Airway Remodeling in Asthma

    Christopher L Grainge;Laurie C K Lau;Jonathon A Ward;Valdeep Dulay

  • Involvement of the epidermal growth factor receptor in epithelial repair in asthma

    S. M. Puddicombe;R. Polosa;A. Richter;M. T. Krishna

  • A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations

    Klaus Bønnelykke;Patrick Sleiman;Kasper Nielsen;Eskil Kreiner-Møller

  • Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

    P H Howarth;K S Babu;H S Arshad;L Lau

  • Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry

    David Holmes;David Pettigrew;Christian H. Reccius;James D. Gwyer

  • Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.

    Coen H. Wiegman;Charalambos Michaeloudes;Gulammehdi Haji;Priyanka Narang

  • The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma

    L. M. Hamilton;C. Torres-Lozano;S. M. Puddicombe;A. Richter

  • Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.

    Phillip D Monk;Richard J Marsden;Victoria J Tear;Jody Brookes

  • Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD

    R A O'Donnell;C Peebles;J A Ward;A Daraker

  • The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma

    Audrey Richter;Sarah M. Puddicombe;James L. Lordan;Fabio Bucchieri

  • Asthmatic Bronchial Epithelium Is More Susceptible to Oxidant-Induced Apoptosis

    Fabio Bucchieri;Sarah M. Puddicombe;James L. Lordan;Audrey Richter

  • The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma.

    C Boxall;S T Holgate;D E Davies

  • Epithelial-mesenchymal communication in the pathogenesis of chronic asthma.

    Stephen T. Holgate;John Holloway;Susan Wilson;Fabio Bucchieri

  • The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.

    Ratko Djukanović;Tim Harrison;Sebastian L. Johnston;Flic Gabbay

  • A new look at the pathogenesis of asthma

    Stephen T. Holgate;Hasan S. Arshad;Graham C. Roberts;Peter H. Howarth

  • Epithelial-mesenchymal interactions in the pathogenesis of asthma

    Stephen T. Holgate;Donna E. Davies;Sarah Puddicombe;Audrey Richter

Frequent Co-Authors

Stephen T. Holgate
Stephen T. Holgate University of Southampton
Peter H. Howarth
Peter H. Howarth University of Southampton
Ratko Djukanovic
Ratko Djukanovic University of Southampton
Susan J. Wilson
Susan J. Wilson University of Southampton
John W. Holloway
John W. Holloway University of Southampton
Luca Richeldi
Luca Richeldi Catholic University of the Sacred Heart
Sebastian L. Johnston
Sebastian L. Johnston Imperial College London
Hywel Morgan
Hywel Morgan University of Southampton
Sumeet Mahajan
Sumeet Mahajan University of Southampton
Graham Roberts
Graham Roberts University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can open diverse career paths. Many professionals transition into specialized roles, such as becoming an acute care nurse practitioner. Programs focused on acute care nurse practitioner programs offer hands-on training for managing critical patient conditions, bridging immunology knowledge with acute care expertise.

Accelerated programs provide efficient pathways for those with a strong foundation in nursing. The accelerated fnp options, in particular, are designed to fast-track family nurse practitioner licensure, enabling students to enter the workforce sooner while building on their clinical skills.

For non-nurses aspiring to enter healthcare, picking the right entry program is crucial. Many turn to the best online rn programs for non nurses to gain the licensing and knowledge necessary to start a nursing career from scratch. These programs emphasize foundational competencies essential to healthcare professions involving immunology.

Additionally, those seeking a more accessible starting point might consider the easiest absn program to get into. Accelerated Bachelor of Science in Nursing (ABSN) programs allow students with prior degrees to transition quickly into nursing, supporting a pathway into specialties like immunology-driven nursing careers.

Best Scientists Citing Donna E. Davies

Trending Scientists

Recently Published Articles